Yay Novartis!!! Way to go! So lucky to be working for this great company! Novartis new number 1 in pharmaceuticals (English translation) The Basel pharmaceutical company Novartis now leads the world ranking of pharmaceutical companies. Based on sales of prescription-only medicines in 2013, Novartis takes the lead for the first time. According to the latest World Preview 2014 report, which the industry service Evaluate Pharma published last week, Novartis has thus overtaken US company Pfizer, which is struggling as patents on its big-selling products start to expire. Novartis showed strong growth in Europe and slight growth in the US, while the sales of Pfizer in both regions declined considerably. Compared with the previous year, the second Basel giant, Roche, climbed two places and now lies in third position. Roche is profiting from its lead in expensive, biotechnologically produced cancer medicines, sales of which showed above-average growth. According to the forecasts of Evaluate Pharma, Roche will move up to second place by 2020, while Novartis will be able to hold on to its lead. The two Swiss companies invest most in research and development by far. And they have well-stocked pipelines of new active substances. This is also paying off on the stock market: according to the auditing company EY, Roche is now the 10th most valuable company with a market value of 256 billion US dollars. Novartis made it to 13th place at 245 billion dollars. Peter Burkhardt Top 10 of the pharmaceutical industry Company Country Sales* Novartis Switzerland 46.0 Pfizer US 45.0 Roche Switzerland 39.1 Sanofi France 37.7 MSD US 37.5 Glaxo Smith Kline Great Britain 33.1 Johnson & Johnson US 26.5 Astra Zeneca Great Britain 24.5 Eli Lilly US 20.1
Posted on: Mon, 07 Jul 2014 14:53:53 +0000